Research Study: Risk benefit analysis – Universities mandate Bivalent boosters that don't work against hospitalizations and increased myocarditis cases.
"…since no prospective randomized placebo controlled trial has demonstrated reductions in Covid-19 hospitalization and death as a primary or secondary endpoint, that theoretic benefit of vaccination could have been dropped to zero."
Comments
Post a Comment